HF
OPA.WS

HRT Financial’s Magnum Opus Acquisition Limited Redeemable Warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50 OPA.WS Stock Holding History

HRT Financial’s Portfolio OPA.WS Stock Details OPA.WS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-38,784
Closed – – 3364
2023
Q4 		$0 Sell
38,784
-982
-2% -$25 ﹤0.01% 3309
2023
Q3 		$1K Sell
39,766
-3,251
-8% -$143 ﹤0.01% 2302
2023
Q2 		$1K Buy
+43,017
New +$2.26K ﹤0.01% 2340

HRT Financial's OPA.WS Position: Q1 2024 in Review

HRT Financial sold out of Magnum Opus Acquisition Limited Redeemable Warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50 (OPA.WS) in Q1 2024, closing a stake of 38,784 shares.

HRT Financial first reported a position in OPA.WS in Q2 2023 and held it in 3 quarters. The position peaked at $1K in Q3 2023. 0 funds tracked by Wall St. Rank hold OPA.WS as of Q1 2024.

  • HRT Financial reported no remaining Magnum Opus Acquisition Limited Redeemable Warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position as of Q1 2024 after selling out during the quarter.
  • HRT Financial sold 38,784 Magnum Opus Acquisition Limited Redeemable Warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50 shares in Q1 2024.
  • HRT Financial first reported a position in Magnum Opus Acquisition Limited Redeemable Warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50 in Q2 2023 and held it in 3 quarters.
  • HRT Financial's Magnum Opus Acquisition Limited Redeemable Warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position peaked at $1K in Q3 2023.
  • 0 funds tracked by Wall St. Rank held Magnum Opus Acquisition Limited Redeemable Warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50 as of Q1 2024.

Based on HRT Financial's 13F filing for Q1 2024, filed 13 May 2024.